Table 6.
Relation between anxiety “Hamilton Anxiety Rating Scale” and different variables
| OR | P | |
|---|---|---|
| Group I (RA) | ||
| Age | 0.98 | 0.13 |
| Sex | 1.1 | 0.17 |
| Marital state | 1.5 | 0.18 |
| Disease duration | 0.92 | 0.12 |
| HCQ stoppage | 1.9 | 0.03* |
| Duration of stoppage | 3.8 | 0.017* |
| CDAI | 1.09 | 0.01 |
| Group II (SLE) | ||
| Age | 2.1 | 0.02* |
| Sex | 0.45 | 0.09 |
| Marital state | 0.9 | 0.17 |
| Disease duration | 0.98 | 0.06 |
| HCQ stoppage | 1.6 | 0.03* |
| Duration of stoppage | 4.2 | 0.04* |
| SELENA | 1.1 | 0.02* |
CDAI clinical disease activity index, RA rheumatoid arthritis, SELENA safety of estrogens in systemic lupus erythematosus national assessment, SLE systemic lupus erythematosus, HCQ hydroxychloroquine
Logistic regression test
*Significant P value if p < 0.05